The experience you want. The resources you need.

PREFILLED SYRINGE MANUFACTURING

BioPharma Solutions’ processes and systems, including high-speed contract manufacturing and automated inspection systems, are tailored to meet your parenteral manufacturing needs.

Global Experience

Experience manufacturing products sold worldwide including North America, South America, Europe and Asia.

Broad Expertise

Serving client needs with clinical through commercial manufacturing, customized support services, and experience with small molecules, biologics, and vaccines (adjuvant & conjugate).

Resources to Get You to Market

By providing high-speed, high-volume syringe filling, with automated inspection, labeling, and packaging equipment that mirrors filling capacity, BioPharma Solutions has the resources to get you to market.

To discuss sterile contract manufacturing services for injectable molecules, please contact us at:  
United States: 1-800-4-BAXTER 
International: 1-2 24-948-4770

Go to article: Home | Ingredients on demandGo to article: In this issueGo to article: Scandinavian HealthGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: Hapa Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The pharma industry briefingGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Scott Gottlieb: achievements of the outgoing FDA commissionerGo to article: CapsugelGo to article: AlpexGo to article: Can Pharmaoffer become the Amazon of pharma raw materials?Go to article: Molnar Company InsightGo to article: MolnarGo to article: Is growth factor protein the future of Parkinson’s treatment?Go to article: AEB Company Insight Go to article: AEB Go to article: CBD: the myth, the magic and the real deal drugsGo to article: Swiss WorldCargoGo to article: Moehs Iberica SLGo to article: Could a pregnancy protein hold promise for new drugs?Go to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Antimicrobial resistance: sewage samples reveal bad sanitation as a key driverGo to article: BEAGo to article: 3MGo to article: PfanstiehlGo to article: EventsGo to article: Richter HelmGo to article: Event: CPhl KoreaGo to article: TSS Company InsightGo to article: TSS ABGo to article: Next issueGo to article: Baxter